-
Start Preamble
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Sigma Aldrich Company LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 20, 2023. Such persons may also file a written request for a hearing on the application on or before March 20, 2023.
ADDRESSES:
The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on January 11, 2023, Sigma Aldrich Company LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118-4103, applied to be registered as an importer of the following basic class(es) of controlled substance(s):
Controlled substance Drug code Schedule Cathinone 1235 I Methcathinone 1237 I Mephedrone (4-Methyl-N-methylcathinone) 1248 I Gamma Hydroxybutyric Acid 2010 I Tetrahydrocannabinols 7370 I 4-Bromo-2,5-dimethoxyamphetamine 7391 I 4-Bromo-2,5-dimethoxyphenethylamine 7392 I 2,5-Dimethoxyamphetamine 7396 I 3,4-Methylenedioxyamphetamine 7400 I 3,4-Methylenedioxy-N-ethylamphetamine 7404 I 3,4-Methylenedioxymethamphetamine 7405 I 4-Methoxyamphetamine 7411 I Dimethyltryptamine 7435 I N-Benzylpiperazine 7493 I Heroin 9200 I Normorphine 9313 I Amobarbital 2125 II Secobarbital 2315 II Nabilone 7379 II Phencyclidine 7471 II Ecgonine 9180 II Ethylmorphine 9190 II Levorphanol 9220 II Meperidine 9230 II Thebaine 9333 II Opium, powdered 9639 II Levo-alphacetylmethadol 9648 II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic Tetrahydrocannabinols. No other activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.
Start SignatureMatthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-03402 Filed 2-16-23; 8:45 am]
BILLING CODE P
Document Information
- Published:
- 02/17/2023
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2023-03402
- Dates:
- Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before March 20, 2023. Such persons may also file a written request for a hearing on the application on or before March 20, 2023.
- Pages:
- 10381-10381 (1 pages)
- Docket Numbers:
- Docket No. DEA-1147
- PDF File:
- 2023-03402.pdf